StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Regen BioPharma's revenue for the twelve months ending Jun 30, 2026 was $236.56K, up 0.0% year over year. For fiscal 2025 it was $236.56K, up 0.0% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is $236.56K in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Sep 30, 2025$236.56K+0.0%
FY2024Sep 30, 2024$236.56K0.0%
FY2023Sep 30, 2023$236.56K+88.5%
FY2022Sep 30, 2022$125.52K+105.1%
FY2021Sep 30, 2021$61.19K-44.4%
FY2020Sep 30, 2020$110.00K0.0%
FY2019Sep 30, 2019$110.00K+10.0%
FY2018Sep 30, 2018$100.00K-9.1%
FY2017Sep 30, 2017$110.00K+10.0%
FY2016Sep 30, 2016$100.00K-47.9%
FY2015Sep 30, 2015$192.00K–
FY2014Sep 30, 2014$0–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$59.07K0.0%
Q2 FY2026CQ1 2026Mar 31, 2026$59.07K0.0%
Q1 FY2026CQ4 2025Dec 31, 2025$59.07K0.0%
Q4 FY2025CQ3 2025Sep 30, 2025$59.37K0.0%
Q3 FY2025CQ2 2025Jun 30, 2025$59.07K0.0%
Q2 FY2025CQ1 2025Mar 31, 2025$59.07K+0.0%
Q1 FY2025CQ4 2024Dec 31, 2024$59.07K0.0%
Q4 FY2024CQ3 2024Sep 30, 2024$59.37K0.0%
Q3 FY2024CQ2 2024Jun 30, 2024$59.07K0.0%
Q2 FY2024CQ1 2024Mar 31, 2024$59.06K+86.7%
Q1 FY2024CQ4 2023Dec 31, 2023$59.07K+86.7%
Q4 FY2023CQ3 2023Sep 30, 2023$59.37K+87.6%
Q3 FY2023CQ2 2023Jun 30, 2023$59.07K+88.8%
Q2 FY2023CQ1 2023Mar 31, 2023$31.64K+2.2%
Q1 FY2023CQ4 2022Dec 31, 2022$31.64K0.0%
Q4 FY2022CQ3 2022Sep 30, 2022$31.64K-1.1%
Q3 FY2022CQ2 2022Jun 30, 2022$31.29K+7.1%
Q2 FY2022CQ1 2022Mar 31, 2022$30.95K+12.8%
Q1 FY2022CQ4 2021Dec 31, 2021$31.64K+15.4%
Q4 FY2021CQ3 2021Sep 30, 2021$31.99K+15.4%
Q3 FY2021CQ2 2021Jun 30, 2021$29.21K+6.5%
Q2 FY2021CQ1 2021Mar 31, 2021$27.43K0.0%
Q1 FY2021CQ4 2020Dec 31, 2020$27.43K0.0%
Q4 FY2020CQ3 2020Sep 30, 2020$27.73K0.0%
Q3 FY2020CQ2 2020Jun 30, 2020$27.43K0.0%
Q2 FY2020CQ1 2020Mar 31, 2020$27.43K0.0%
Q1 FY2020CQ4 2019Dec 31, 2019$27.43K0.0%
Q4 FY2019CQ3 2019Sep 30, 2019$27.73K–
Q3 FY2019CQ2 2019Jun 30, 2019$27.43K-72.6%
Q2 FY2019CQ1 2019Mar 31, 2019$27.43K–
Q1 FY2019CQ4 2018Dec 31, 2018$27.43K–
Q4 FY2018CQ3 2018Sep 30, 2018$0–
Q3 FY2018CQ2 2018Jun 30, 2018$100.00K-9.1%
Q2 FY2018CQ1 2018Mar 31, 2018$0–
Q1 FY2018CQ4 2017Dec 31, 2017$0–
Q4 FY2017CQ3 2017Sep 30, 2017$0-100.0%
Q3 FY2017CQ2 2017Jun 30, 2017$110.00K–
Q2 FY2017CQ1 2017Mar 31, 2017$0–
Q1 FY2017CQ4 2016Dec 31, 2016$0–
Q4 FY2016CQ3 2016Sep 30, 2016$100.00K–

More Regen BioPharma figures

See a number that looks wrong?